Tech Company Financing Transactions
Voyager Therapeutics Funding Round
Third Rock Ventures and private investors joined a $45 million Series A funding round for Voyager Therapeutics. The round was announced by the company on 2/13/2014.
Transaction Overview
Company Name
Announced On
2/13/2014
Transaction Type
Venture Equity
Amount
$45,000,000
Round
Series A
Investors
Third Rock Ventures (Mark Levin)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
75 Sidney St.
Cambridge, MA 02139
USA
Cambridge, MA 02139
USA
Phone
Website
Email Address
Overview
Voyager Therapeutics (NASDAQ: VYGR) is developing life-changing gene therapies for fatal and debilitating diseases of the central nervous system. Our founders include scientific and clinical leaders in the fields of adeno-associated virus (AAV) gene therapy, expressed RNA interference and neuroscience.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Andre Turenne
Chief Scientific Officer
Dinah Sah
VP - Human Resources
Kathleen Hayes
VP - Regulatory Affairs
Robert Pietrusko
Browse more venture capital transactions:
Prev: 2/13/2014: Curious.com venture capital transaction
Next: 2/13/2014: Life On Air venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to report on all VC transactions involving tech companies. VC investment data records reported here are sourced from a variety of public sources. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs